CN1352966A - Medicine for treating tracheitis and asthma - Google Patents

Medicine for treating tracheitis and asthma Download PDF

Info

Publication number
CN1352966A
CN1352966A CN 00132238 CN00132238A CN1352966A CN 1352966 A CN1352966 A CN 1352966A CN 00132238 CN00132238 CN 00132238 CN 00132238 A CN00132238 A CN 00132238A CN 1352966 A CN1352966 A CN 1352966A
Authority
CN
China
Prior art keywords
radix
asthma
rhizoma
medicine
processed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 00132238
Other languages
Chinese (zh)
Inventor
李庆福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00132238 priority Critical patent/CN1352966A/en
Publication of CN1352966A publication Critical patent/CN1352966A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in different dosage forms such as decoction for treating tracheitis and asthma is prepared from 23 Chinese medicinal materials includign Chuan-xiong rhizome, liquorice root, schisandra fruit, mulberry bark, etc. through proportioning and unique preparing process. Its advantages include both treating both principal and secondary aspects of disease and high curative effect.

Description

The medicine of treatment tracheitis, asthma
The present invention relates to a kind of medicine for the treatment of tracheitis, asthma, specifically a kind of is the treatment tracheitis made of raw material, the Chinese patent medicine of asthma with the Chinese herbal medicine.
Tracheitis, asthma are a kind of common diseases, bring great misery for patient's body and mind, are seriously endangering people's physical and mental health.Medical circle adopts western medicine for this type of disease more at present, and a class is the relaxing smooth muscle medicine, and another kind of is hormone medicine.Though this two classes medicine respite occurring degree is difficult to reach radical cure, and life-time service easily causes drug dependence, and side effect is very big.
The object of the present invention is to provide a kind of medicine for the treatment of tracheitis, asthma, can comparatively fast eliminate the cough with asthma symptom, eliminate the disorderly phenomenon of increased bronchovascular shadows, the lung marking intercostal space is dwindled, diaphram descends, and instant effect, curative effect height, has no side effect.
Solution of the present invention is based on the pathogenetic understanding of motherland's medical science to tracheitis, asthma, filters out from motherland's medical treasure-house that vital energy benefiting and the kidney invigorating, removing heat from the lung and dissipating phlegm, soothing liver-QI are invigorated blood circulation, the natural drug prescription of relieving cough and asthma forms.Think that the pathogeny of tracheitis, asthma is by being hindered because of feelings will, deficiency of spleen-YANG and kidneyYANG, exopathogen are invaded and are caused the internal organs imbalance of YIN and YANG, make kidney,spleen,liver, lung disequilibrium, mental disorder Yong Sheng, stop up air flue and fall ill, overstrain internal injury, feelings will be unsuccessful so that weakened defensive QI is suddenly fallen ill.So the ruling by law of invigorating blood circulation with vital energy benefiting and the kidney invigorating, removing heat from the lung and dissipating phlegm, soothing liver-QI it.
Medicine of the present invention is made (consumption is a weight portion) by following ingredients:
Rhizoma Chuanxiong 10-20 Radix Glycyrrhizae 10-20 Fructus Schisandrae Chinensis 10-20
Cortex Mori 10-20 Semen Armeniacae Amarum 10-20 Fructus Crataegi 10-20
Rhizoma Coptidis 4-8 Bulbus Fritillariae Cirrhosae 10-20 Rhizoma Zingiberis 4-8
Radix Angelicae Sinensis 10-20 Poria 10-20 Radix Sophorae Tonkinensis 10-20
Radix Salviae Miltiorrhizae 15-25 Radix Bupleuri 10-15 Fructus Cucumidis sativi 10-20
Radix Isatidis 10-20 Radix Rehmanniae Preparata 5-15 Flos Chrysanthemi 15-25
Carapax Trionycis (processed) 10-20 Radix Codonopsis 10-20 10-20 Radix Ophiopogonis
Grilled chicken Endothelium corneum 15-25 Rhizoma Pinelliae (processed) 10-20
Formula optimization weight (part) ratio range of preparation medicine of the present invention is:
Rhizoma Chuanxiong 15 Radix Glycyrrhizaes 15 Fructus Schisandrae Chinensis 15
Cortex Mori 15 Semen Armeniacae Amarums 15 Fructus Crataegis 15
Rhizoma Coptidis 6 Bulbus Fritillariae Cirrhosaes 15 Rhizoma Zingiberiss 6
Radix Angelicae Sinensis 15 Poria 15 Radix Sophorae Tonkinensiss 15
Radix Salviae Miltiorrhizae 20 Radix Bupleuri 12 Fructus Cucumidiss sativi 15
Radix Isatidis 15 Radix Rehmanniaes Preparata 10 Flos Chrysanthemis 20
15 Radix Ophiopogonis 15 of Carapax Trionycis (processed) 15 Radix Codonopsis
Grilled chicken Endothelium corneum 20 Rhizoma Pinelliae (processed) 15
Medicine of the present invention be crude drug, start with from the cause of disease of tracheitis, asthma, according to cause of disease medication, regulate the bodily fuctions, improve function of human body, the combination of inner and outside, pleasant invigorating blood circulation finally reaches the purpose for the treatment of both the principal and secondary aspects of a disease.
The present invention can make various dosage forms according to a conventional method, preferred decoction type in various dosage forms.
The symptom of tracheitis, asthma can be eliminated and alleviate to medicine treating both the principal and secondary aspects of a disease of the present invention quickly, eliminates the disorderly phenomenon of increased bronchovascular shadows.This drug administration is convenient, and patient easily accepts, and side effect is little, and expense is low, instant effect, and the overwhelming majority is difficult for recurrence.
Embodiment
Embodiment 1: preparation method
Take by weighing crude drug (unit is gram) according to following prescription and consumption:
Rhizoma Chuanxiong 15 Radix Glycyrrhizaes 15 Fructus Schisandrae Chinensis 15
Cortex Mori 15 Semen Armeniacae Amarums 15 Fructus Crataegis 15
Rhizoma Coptidis 6 Bulbus Fritillariae Cirrhosaes 15 Rhizoma Zingiberiss 6
Radix Angelicae Sinensis 15 Poria 15 Radix Sophorae Tonkinensiss 15
Radix Salviae Miltiorrhizae 20 Radix Bupleuri 12 Fructus Cucumidiss sativi 15
Radix Isatidis 15 Radix Rehmanniaes Preparata 10 Flos Chrysanthemis 20
15 Radix Ophiopogonis 15 of Carapax Trionycis (processed) 15 Radix Codonopsis
Grilled chicken Endothelium corneum 20 Rhizoma Pinelliae (processed) 15
Wherein the concocting method of Rhizoma Pinelliae (processed) is: after fresh Rhizoma Zingiberis Recens 20 grams are smashed, extrude Jiang Shui, mix in the 15 gram Rhizoma Pinelliaes, mix thoroughly, fry in pot to jaundice with sand.
Add entry after above-mentioned crude drug mixed, decocted 1.5 hours, remove slag, filter 1000 milliliters of patent medicine, in the sub-bottling, 500 milliliters every bottle.
Embodiment 2: clinical trial
For showing the therapeutic effect of medicine of the present invention to tracheitis, asthma, all types of tracheitiies, asthma and all ages and classes have been selected by system, and the case of sex uses medicine of the present invention to treat, and be 18 days a course of treatment.
Instructions of taking: every day three times, a drug 250-300 milliliter, treatment cycle is three courses of treatment.Therapeutic effect can be added up referring to table 1 clinical data.
Produce effects: cough with asthma disappears, and increased bronchovascular shadows is disorderly to disappear,
Effectively: cough with asthma alleviates, and increased bronchovascular shadows is disorderly to be reduced, and fibrosis occurs.
Invalid: cough with asthma still exists, lung marking intercostal space and diaphram no change.
Table 1 clinical data statistics
Disease Case load (people) Produce effects Effectively Invalid Effective percentage
Tracheitis ????2168 ??1399 ??732 ??37 ??98.3%
Asthma ????1956 ??1243 ??695 ??18 ??99.1%
Total effective rate 98.7%
By above-mentioned clinical data as seen, the symptom of tracheitis, asthma can be eliminated and alleviate to medicine treating both the principal and secondary aspects of a disease of the present invention quickly, eliminates the disorderly phenomenon of increased bronchovascular shadows.This drug administration is convenient, and patient easily accepts, and side effect is little, and expense is low, instant effect, and the overwhelming majority is difficult for recurrence.
Embodiment 3: model case
1. grandson state minister, the man, 58 years old, Dakui town, Xinmi City, Henan Province Dakui people from village suffered from one's early years
Tracheitis is arranged, just begin, have an attack of one's old illness during season alternation, develop into warp throughout the year at last
Normal outbreak was kept by the clothes Western medicine throughout the year, took three of medicines of the present invention since 92 years
Other any medicines were not taken in i.e. recovery from illness so far again after the course of treatment, did not have recurrence again.
2. Li Bin, the man, 23 years old, No. 39, North Road, Central Region, Lanzhou City, Gansu Province suffered from the time of 8 years old
Asthma is had no result through seeking medical advice in many ways, and through looking into the broadening of patient intercostal space, lung marking is big and heavy,
Disorder, moving difficulty at ordinary times, disability is then panted endlessly in an activity slightly.
Promptly fully recover after a course of treatment since taking medicine of the present invention, through follow-up examination, rabat is extensive
Multiple normal, asthma is not reaccessed, and recovers normal work capacity.

Claims (5)

1. medicine for the treatment of tracheitis, asthma is characterized in that it is the medicament of being made according to conventional method by the following weight proportion raw material:
Rhizoma Chuanxiong 10-20 Radix Glycyrrhizae 10-20 Fructus Schisandrae Chinensis 10-20
Cortex Mori 10-20 Semen Armeniacae Amarum 10-20 Fructus Crataegi 10-20
Rhizoma Coptidis 4-8 Bulbus Fritillariae Cirrhosae 10-20 Rhizoma Zingiberis 4-8
Radix Angelicae Sinensis 10-20 Poria 10-20 Radix Sophorae Tonkinensis 10-20
Radix Salviae Miltiorrhizae 15-25 Radix Bupleuri 10-15 Fructus Cucumidis sativi 10-20
Radix Isatidis 10-20 Radix Rehmanniae Preparata 5-15 Flos Chrysanthemi 15-25
Carapax Trionycis (processed) 10-20 Radix Codonopsis 10-20 10-20 Radix Ophiopogonis
Grilled chicken Endothelium corneum 15-25 Rhizoma Pinelliae (processed) 10-20
2. the medicine of treatment tracheitis according to claim 1, asthma, wherein the weight proportion of each raw material is:
Rhizoma Chuanxiong 15 Radix Glycyrrhizaes 15 Fructus Schisandrae Chinensis 15
Cortex Mori 15 Semen Armeniacae Amarums 15 Fructus Crataegis 15
Rhizoma Coptidis 6 Bulbus Fritillariae Cirrhosaes 15 Rhizoma Zingiberiss 6
Radix Angelicae Sinensis 15 Poria 15 Radix Sophorae Tonkinensiss 15
Radix Salviae Miltiorrhizae 20 Radix Bupleuri 12 Fructus Cucumidiss sativi 15
Radix Isatidis 15 Radix Rehmanniaes Preparata 10 Flos Chrysanthemis 20
15 Radix Ophiopogonis 15 of Carapax Trionycis (processed) 15 Radix Codonopsis
Grilled chicken Endothelium corneum 20 Rhizoma Pinelliae (processed) 15
3. the medicine of treatment tracheitis according to claim 1 and 2, asthma is characterized in that said medicament is a said dosage form on any pharmaceutics.
4. the medicine of treatment tracheitis according to claim 3, asthma is characterized in that said medicament is a decoction.
5. the medicine of treatment tracheitis according to claim 1 and 2, asthma, the concocting method that it is characterized in that said Rhizoma Pinelliae (processed) is after fresh Rhizoma Zingiberis Recens 20 grams are smashed, to extrude Jiang Shui, mixes in the 15 gram Rhizoma Pinelliaes, mix thoroughly, frying extremely in pot with sand, jaundice gets final product.
CN 00132238 2000-11-10 2000-11-10 Medicine for treating tracheitis and asthma Pending CN1352966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00132238 CN1352966A (en) 2000-11-10 2000-11-10 Medicine for treating tracheitis and asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00132238 CN1352966A (en) 2000-11-10 2000-11-10 Medicine for treating tracheitis and asthma

Publications (1)

Publication Number Publication Date
CN1352966A true CN1352966A (en) 2002-06-12

Family

ID=4595068

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00132238 Pending CN1352966A (en) 2000-11-10 2000-11-10 Medicine for treating tracheitis and asthma

Country Status (1)

Country Link
CN (1) CN1352966A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100431583C (en) * 2006-04-29 2008-11-12 金方义 A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same
CN102188573A (en) * 2011-04-16 2011-09-21 马秋霞 Chinese medicinal composition for treating bronchial asthma
CN102793840A (en) * 2012-08-24 2012-11-28 内蒙古鄂尔多斯市蒙医研究所 Mongolian compound preparation for treating bronchitis and preparation method thereof
CN108815366A (en) * 2018-07-18 2018-11-16 袁春续 A kind of enriching yin cough-relieving formula

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100431583C (en) * 2006-04-29 2008-11-12 金方义 A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same
CN102188573A (en) * 2011-04-16 2011-09-21 马秋霞 Chinese medicinal composition for treating bronchial asthma
CN102188573B (en) * 2011-04-16 2013-03-27 马秋霞 Chinese medicinal composition for treating bronchial asthma
CN102793840A (en) * 2012-08-24 2012-11-28 内蒙古鄂尔多斯市蒙医研究所 Mongolian compound preparation for treating bronchitis and preparation method thereof
CN108815366A (en) * 2018-07-18 2018-11-16 袁春续 A kind of enriching yin cough-relieving formula

Similar Documents

Publication Publication Date Title
CN1317027C (en) Chinese medicine for treating depression
CN101028507A (en) Chinese-medicinal composition for treating asthma
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN1724040A (en) Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method
CN1692939A (en) Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method
CN1336219A (en) Gynopathy treating traditional Chinese medicine
CN103736018A (en) Medicine for treating gallstones and preparation method thereof
CN1087625C (en) Traditional Chinese medicine preparation for treating colitis
CN1074281C (en) Chinese medicine prepn
CN116139237B (en) A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application
CN103142920A (en) Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
CN102973758A (en) Traditional Chinese medicine composition for treating depression
CN1063954C (en) Chinese patent medicine-powder preparation for curing hepatitis B
CN1066628C (en) Medicine for chronic hepatitis B and its preparation
CN1352966A (en) Medicine for treating tracheitis and asthma
CN101199749A (en) Chinese medicine for treating AIDS
CN1422649A (en) Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease
CN105902888A (en) Traditional Chinese medicine decoction for treating infantile acute nephritis
CN1059104C (en) Capsule for anti hepatitis B
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN1165691A (en) Cream for relieving cough and asthma
CN1302804C (en) Drug addiction-stopping medicine
CN111110782B (en) Application of traditional Chinese medicine composition in preparation of medicine for treating cold
CN1059590C (en) Medicine for blood generation and preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication